Paper4211992
Evaluation in nonhuman primates: evaluation of the physical dependence capacities of oripavine-thebaine partial agonists in patas monkeys.
Cowan A. Adv Biochem Psychopharmacol, 1973. Cited by 22 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Evaluation in nonhuman primates: evaluation of the physical dependence capacities of oripavine-thebaine partial agonists in patas monkeys. Papers, record 4211992. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4211992
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Evaluation in nonhuman primates: evaluation of the physical dependence capacities of oripavine-thebaine partial agonists in patas monkeys.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Analgesics | Major topic |
| Narcotic Antagonists | Major topic |
| Substance Withdrawal Syndrome | Major topic |
| Substance-Related Disorders | Major topic |
| Thebaine | Major topic |
| Animals | |
| Cyclazocine | |
| Female | |
| Haplorhini | |
| Humans | |
| Male | |
| Mice | |
| Morphinans | |
| Morphine | |
| Morphine Dependence | |
| Nalorphine | |
| Naloxone | |
| Pentazocine | |
| Stereotyped Behavior | |
| Time Factors |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 28,446,883 | In Vitro and In Vivo Profile of PPL-101 and PPL-103: Mixed Opioid Partial Agonist Analgesics with Low Abuse Potential. | Front Psychiatry | 2017 | https://conductscience.org/library/papers/28446883 | PubMed |
| 21,051,498 | Buprenorphine and opioid antagonism, tolerance, and naltrexone-precipitated withdrawal. | J Pharmacol Exp Ther | 2011 | https://conductscience.org/library/papers/21051498 | PubMed |
| 6,291,084 | Discriminative stimulus properties of naloxone. | Psychopharmacology (Berl) | 1982 | https://conductscience.org/library/papers/6291084 | PubMed |
| 4,597,802 | A role for the amygdala in the development of the cataleptic and stereotypic actions of the narcotic agonists and antagonists in the rat. | Psychopharmacologia | 1974 | https://conductscience.org/library/papers/4597802 | PubMed |
| 4,476,081 | Antagonism of morphine by long acting narcotic antagonists. | Psychopharmacologia | 1974 | https://conductscience.org/library/papers/4476081 | PubMed |
| 3,137,619 | Diprenorphine and naloxone in squirrel monkeys with enhanced sensitivity to opioid antagonists. | Psychopharmacology (Berl) | 1988 | https://conductscience.org/library/papers/3137619 | PubMed |
| 572,694 | Mixed agonist-antagonist opiates and physical dependence. | Br J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/572694 | PubMed |
| 409,448 | Agonist and antagonist properties of buprenorphine, a new antinociceptive agent. | Br J Pharmacol | 1977 | https://conductscience.org/library/papers/409448 | PubMed |
| 378,645 | Buprenorphine: a review of its pharmacological properties and therapeutic efficacy. | Drugs | 1979 | https://conductscience.org/library/papers/378645 | PubMed |
| 207,560 | Behavioural effects of naloxone in rats. | Experientia | 1978 | https://conductscience.org/library/papers/207560 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4211992
GET https://conductscience.org/api/papers/v1/4211992/authors